Filters

ABTB2 Antibody

ABTB2 Antibody size: 0.08 ml 199

Supplier NJS POLY
Price 199
Size 0.08 ml
CategoryAntibody
Concentration pH 7, with 0, 09% sodium azide, 4, In 1X PBS
FormAntigen affinity purified
ConjugationUnconjugated
ClonePolyclonal antibody
Recognised antigenABTB2
Host animalRabbit (Oryctolagus cuniculus)
ClonalityPolyclonal (rabbit origin)
Species reactivity Due to limited knowledge and inability to test the antibody against all known species, we cannot guarantee that no other cross reactivity can occur, Human (Homo sapiens)
Tested applications ELISA, WB
Recommended dilutionsWestern blot: 1:1000
Intented useThis ABTB2 antibodyis to be used only for research purposes and not for diagnostics
Uniprot #Q8N961
PurityAntigen affinity
DescriptionAnkyrin repeat and BTB/POZ domain-containing protein 2 may be involved in the initiation of hepatocyte growth (By similarity)
ImmunogenA portion of amino acids 681-710 from the human protein was used as the immunogen for this ABTB2 antibody
Storage Celcius or lower, Cycles of freezing and thawing can denaturate the peptide chains of the antibodies and reduce their sensitivity and/or change their affinity, Prepare aliqotes in such a manner so that freeze-thaw cycles are minimized, Aliquot the ABTB2 antibody and store frozen at -20 deg
PropertiesC, C for long term storage and for short term at + 5°, If you buy Antibodies supplied by NJS poly they should be stored frozen at - 24°
Gene targetABTB2
Short nameABTB2 Antibody
Technique antibodies against human proteins, antibodies for, Antibody
Alternative nameABTB2 (Antibody to)
Alternative techniqueantibodies
Identity 23842
Gene ABTB2
Long gene name ankyrin repeat and BTB domain containing 2
Synonyms gene name ankyrin repeat and BTB (POZ) domain containing 2
Synonyms DKFZP586C1619 BTBD22 ABTB2A
Locus 11p13
Discovery year 2003-12-15
GenBank acession AK056863
Entrez gene record 25841
RefSeq identity NM_145804
Classification BTB domain containing Ankyrin repeat domain containing
Havana BLAST/BLAT OTTHUMG00000044382

Subscribe to our Newsletter